Dr. Sahajal Dhooria’s major area of interest in research is sarcoidosis and other diffuse lung diseases. He was the lead investigator of the SARCORT trial that established low-dose prednisolone as a good alternative to a high-dose regimen for treating sarcoidosis. He has worked extensively on the diagnosis of sarcoidosis and hypersensitivity pneumonitis. He has published 379 PubMed indexed articles and has a Google Scholar H-index of 59.